HDAC9 and lung carcinoma: In previously published work, we reported that Dorsomorphin (AMPK inhibitor) and KU-60019 (ATM kinase inhibitor) up-regulate and Trichostatin A (HDAC inhibitor and AMPK activator) down-regulates RASSF1C mRNA levels in lung cancer cells [17].